Antheia, Inc.
Antheia is a biotech company that uses biosynthesis to produce pharmaceutical ingredients faster and more efficiently than traditional methods. It has raised $244M in funding and employs 67 people. Antheia provides pharmaceutical companies with a more resilient supply chain for critical ingredients. Its technology platform reduces production time and supply chain risks, enabling faster innovation in therapeutic development. The company has attracted significant investment, including from America’s Frontier Fund and Civilization Ventures, and is recognized by the U.S. government as a priority technology for public health and national security. Antheia’s leadership team includes experts in biosynthesis and pharmaceutical manufacturing. The company’s largest function is Research, which accounts for 25 of its 67 employees. Its workforce is concentrated in Menlo Park, California, where it was founded in 2015. Antheia’s talent pool includes alumni from Amyris, Zymergen, and Intrexon, with strong representation from the University of California, Berkeley, and Stanford University. Its employees have moved on to roles at Genentech, Septerna, and Amazon. Antheia’s alumni have founded three companies, including Revel Pharmaceuticals, Stellarus Intelligence, and ExoPolymer.
The growth story
Antheia, Inc. grew from 31 to 67 employees between 2021 and 2026, raising $244M along the way, most recently a Series C in January 2026.
About
Antheia develops biosynthesis technology to produce pharmaceutical ingredients more efficiently than traditional methods. Its platform reduces production time and supply chain risks, enabling faster innovation in therapeutic development. The company serves global pharmaceutical customers, providing a resilient supply of critical ingredients at scale.
Antheia has raised $244M in funding, including a Series C round in January 2026. Its investors include America’s Frontier Fund and Civilization Ventures. The company employs 67 people, with its largest function being Research, which accounts for 25 employees.
Founders and leadership
Antheia’s largest function is Research, which accounts for 25 of its 67 employees. The company is headquartered in Menlo Park, California, and was founded in 2015. Its leadership team includes experts in biosynthesis and pharmaceutical manufacturing.
The Antheia, Inc. org chart
Christina Smolke (CEO & Co-Founder) leads 23 mapped leaders with 4 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 29 (+12% YoY), Operations 8 (-11% YoY), Engineering 6 (+20% YoY), Business Development 6 (+20% YoY), Finance 3 (+50% YoY).
Talent flow
Antheia’s talent pool includes alumni from Amyris, Zymergen, and Intrexon, with strong representation from the University of California, Berkeley, and Stanford University. Its employees have moved on to roles at Genentech, Septerna, and Amazon.
Most common previous employers of Antheia, Inc. staff: Amyris (9), Zymergen (4), Intrexon (3), University of California, Berkeley (3), Stanford University (3), Evolutia Bio (2). Former Antheia, Inc. employees most often moved to Genentech (3), Septerna (2), DropGenie (1), 500 Global (1), Amazon (1), Revel Pharmaceuticals (1).
Alumni worth knowing
The Antheia, Inc. mafia
Antheia’s alumni have founded three companies, including Revel Pharmaceuticals, Stellarus Intelligence, and ExoPolymer.
3Aaron Cravens, was Consultant until 2020Kristin Smith, was General Counsel and Director of Intellectual Property until 2022Derek Wells, was CTO, Director of Protein Engineering until 2017Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Antheia, Inc.: Microsoft Office (20), Molecular Biology (19), Polymerase Chain Reaction (PCR) (18), Research Skills (17), Leadership (17), Biotechnology (17), Microsoft Excel (15), Fermentation (14).
Where the team actually sits
Antheia, Inc. people are concentrated in California, United States (30), San Francisco Bay Area (21), Singapore (2), United States (2).
Search footprint
Antheia, Inc. attracts about 670 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 83 ranking keywords and lost 68 in the last period.
What employees say
- Compensation
- 3.50 / 5
- Career opportunities
- 3.30 / 5
- Senior management
- 3.40 / 5
- Work-life balance
- 3.70 / 5
Frequently asked
Antheia, Inc. has 67 employees as of September 2026.
Antheia, Inc. has raised $244M in total, most recently a Series C round in January 2026.
Antheia, Inc. was founded in 2015 by Christina Smolke, Kristy Hawkins.
Christina Smolke (CEO & Co-Founder) sits at the top of Antheia, Inc.'s reporting structure, with 4 direct reports.
The most common previous employers of current Antheia, Inc. staff are Amyris (9 people), Zymergen (4 people), Intrexon (3 people).
Former Antheia, Inc. employees most often move to Genentech (3), Septerna (2), DropGenie (1).
At least 3 companies have a founder who previously worked at Antheia, Inc., including Revel Pharmaceuticals, Stellarus Intelligence, ExoPolymer.
Antheia, Inc. attracts about 670 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among Antheia, Inc. staff are Microsoft Office, Molecular Biology, Polymerase Chain Reaction (PCR), Research Skills, Leadership.
Antheia, Inc. staff are concentrated in California, United States (30), San Francisco Bay Area (21), Singapore (2).
Antheia, Inc. has about 29 people in Research, up 12% over the past year, as of September 2026.
Antheia, Inc. has about 8 people in Operations, down 11% over the past year, as of September 2026.
Computed from 60 current and 44 former Antheia, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.